Gufic Biosciences Ltd vs Speciality Medicines Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Gufic BioSciences Ltd is ₹ 371.3 as of 12 Jun 15:30 . The P/E Ratio of Gufic BioSciences Ltd is 33 as of March 2024 .The P/E Ratio of Speciality Medicines Ltd is 0 as of March 2024 . The Market Cap of Gufic BioSciences Ltd is ₹ 2839 crore as of March 2024 .The Market Cap of Speciality Medicines Ltd is ₹ 0 crore as of March 2024 . The revenue of Gufic BioSciences Ltd for the Mar '26 is ₹ 250.65 crore as compare to the Dec '25 revenue of ₹ 232.2 crore. This represent the growth of 7.95% The revenue of Speciality Medicines Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gufic BioSciences Ltd for the Mar '26 is ₹ 46.04 crore as compare to the Dec '25 ebitda of ₹ 33.77 crore. This represent the growth of 36.33% The ebitda of Speciality Medicines Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gufic BioSciences Ltd changed from ₹ 20.86 crore to ₹ 21.9 crore over 8 quarters. This represents a CAGR of 2.46% The net profit of Speciality Medicines Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gufic BioSciences Ltd changed from 2.19 % on March 2021 to 1.43 % on March 2025 . This represents a CAGR of -8.17% over 5 yearsThe Dividend Payout of Speciality Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Gufic BioSciences Ltd

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
The Company was incorporated in July, 1984.
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

About Speciality Medicines Ltd

Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

FAQs for the comparison of Gufic BioSciences Ltd and Speciality Medicines Ltd

Which company has a larger market capitalization, Gufic BioSciences Ltd or Speciality Medicines Ltd?

Market cap of Gufic BioSciences Ltd is 3,723 Cr while Market cap of Speciality Medicines Ltd is 178 Cr

What are the key factors driving the stock performance of Gufic BioSciences Ltd and Speciality Medicines Ltd?

The stock performance of Gufic BioSciences Ltd and Speciality Medicines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gufic BioSciences Ltd and Speciality Medicines Ltd?

As of June 14, 2026, the Gufic BioSciences Ltd stock price is INR ₹371.3. On the other hand, Speciality Medicines Ltd stock price is INR ₹203.0.

How do dividend payouts of Gufic BioSciences Ltd and Speciality Medicines Ltd compare?

To compare the dividend payouts of Gufic BioSciences Ltd and Speciality Medicines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.